Promising Initial Phase 2 Results of Acute Myeloid Leukemia Treatment

BioLineRx Announces Promising Initial Phase 2 Results of Acute Myeloid Leukemia Treatment Initial results for BKT-140/BL-8040 show substantial mobilization of cancer cells and signs of robust cancer cell death (apoptosis). Read More

Positive Preclinical Results of Acute Myeloid Leukemia Treatment at ASH Conference

BioLineRx Presents Positive Preclinical Results of Acute Myeloid Leukemia Treatment at ASH Conference BKT-140/BL-8040 is currently in Phase 2 study in AML patients, with partial results expected this month and final results expected in H2 2014. Read More

Go to Top